» Articles » PMID: 27536992

SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa Cells Under Osmotic Stress: In Vitro and In Silico Insights

Overview
Journal PLoS One
Date 2016 Aug 19
PMID 27536992
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

SIRT6 is a protein deacetylase, involved in various intracellular processes including suppression of glycolysis and DNA repair. Aldose Reductase (AR), first enzyme of polyol pathway, was proposed to be indirectly associated to these SIRT6 linked processes. Despite these associations, presence of SIRT6 based regulation of AR still remains ambiguous. Thus, regulation of AR expression by SIRT6 was investigated under hyperosmotic stress. A unique model of osmotic stress in U937 cells was used to demonstrate the presence of a potential link between SIRT6 and AR expression. By overexpressing SIRT6 in HeLa cells under hyperosmotic stress, its role on upregulation of AR was revealed. In parallel, increased SIRT6 activity was shown to upregulate AR in U937 cells under hyperosmotic milieu by using pharmacological modulators. Since these modulators also target SIRT1, binding of the inhibitor, Ex-527, specifically to SIRT6 was analyzed in silico. Computational observations indicated that Ex-527 may also target SIRT6 active site residues under high salt concentration, thus, validating in vitro findings. Based on these evidences, a novel regulatory step by SIRT6, modifying AR expression under hyperosmotic stress was presented and its possible interactions with intracellular machinery was discussed.

Citing Articles

SIRT3/6: an amazing challenge and opportunity in the fight against fibrosis and aging.

Wei W, Li T, Chen J, Fan Z, Gao F, Yu Z Cell Mol Life Sci. 2024; 81(1):69.

PMID: 38294557 PMC: 10830597. DOI: 10.1007/s00018-023-05093-z.


Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.

Raghu S, Bangalore Prabhashankar A, Shivanaiah B, Tripathi E, Sundaresan N Subcell Biochem. 2022; 100:337-360.

PMID: 36301499 DOI: 10.1007/978-3-031-07634-3_10.


SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Chang A, Ferrer C, Mostoslavsky R Physiol Rev. 2019; 100(1):145-169.

PMID: 31437090 PMC: 7002868. DOI: 10.1152/physrev.00030.2018.


Molecular Insights into the Interaction of RONS and Thieno[3,2-c]pyran Analogs with SIRT6/COX-2: A Molecular Dynamics Study.

Yadav D, Kumar S, Saloni , Misra S, Yadav L, Teli M Sci Rep. 2018; 8(1):4777.

PMID: 29556059 PMC: 5859274. DOI: 10.1038/s41598-018-22972-9.

References
1.
Ramana K, Srivastava S . Aldose reductase: a novel therapeutic target for inflammatory pathologies. Int J Biochem Cell Biol. 2009; 42(1):17-20. PMC: 2787653. DOI: 10.1016/j.biocel.2009.09.009. View

2.
Schymkowitz J, Rousseau F, Martins I, Ferkinghoff-Borg J, Stricher F, Serrano L . Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc Natl Acad Sci U S A. 2005; 102(29):10147-52. PMC: 1177371. DOI: 10.1073/pnas.0501980102. View

3.
Gertz M, Fischer F, Nguyen G, Lakshminarasimhan M, Schutkowski M, Weyand M . Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism. Proc Natl Acad Sci U S A. 2013; 110(30):E2772-81. PMC: 3725051. DOI: 10.1073/pnas.1303628110. View

4.
Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A . SIRT6 promotes DNA repair under stress by activating PARP1. Science. 2011; 332(6036):1443-6. PMC: 5472447. DOI: 10.1126/science.1202723. View

5.
Zhao X, Allison D, Condon B, Zhang F, Gheyi T, Zhang A . The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. J Med Chem. 2013; 56(3):963-9. DOI: 10.1021/jm301431y. View